Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B.

about

Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy?Uncontrolled pneumonia in a 49-year-old white man.Coccidioidomycosis and Blastomycosis: Endemic Mycotic Co-Infections in the HIV Patient

P2860

Q26740363-1213C6BF-6880-4044-BD44-778369CD2465 Q40191211-B09E4376-C42C-4FF1-99F1-39434A104781 Q41547292-185F7ED2-29FF-4AC4-B791-92A66AA0DCE9

P2860

Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B.

Item

http://www.wikidata.org/entity/Q40247785

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Successful treatment of pulmon ...... with liposomal amphotericin B.

@en

type

Item

label

Successful treatment of pulmon ...... with liposomal amphotericin B.

@en

prefLabel

Successful treatment of pulmon ...... with liposomal amphotericin B.

@en

P1476

Successful treatment of pulmon ...... with liposomal amphotericin B

@en

P2093

Bradley R Mitchelmore

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

Recurrent blastomycosis of the central nervous system: case report and review.

Do in vitro susceptibility data predict the microbiologic response to amphotericin B? Results of a prospective study of patients with Candida fungemia.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans.

Plasma protein binding of amphotericin B and pharmacokinetics of bound versus unbound amphotericin B after administration of intravenous liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate

Pharmacokinetic-pharmacodynamic comparison of amphotericin B (AMB) and two lipid-associated AMB preparations, liposomal AMB and AMB lipid complex, in murine candidiasis models.

Antifungal pharmacokinetics and pharmacodynamics: bridging from the bench to bedside.

Antifungal PK/PD considerations in fungal pulmonary infections.

Comparative efficacies of amphotericin B lipid complex and amphotericin B deoxycholate suspension against murine blastomycosis.

P304

e26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1R703

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sheryl A. Zelenitsky

Robert E Ariano

Philippe Lagacé-Wiens

P577

2013-05-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23673538

http://www.w3.org/2001/XMLSchema#string

Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B.

about

P2860

P2860

Successful treatment of pulmonary blastomycosis with continuously infused amphotericin B deoxycholate after failure with liposomal amphotericin B.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698